Kovatchev, Boris P.
Colmegna, Patricio
Pavan, Jacopo
Diaz CastaƱeda, Jenny L.
Villa-Tamayo, Maria F.
Koravi, Chaitanya L. K.
Santini, Giulio
Alix, Carlene
Stumpf, Meaghan
Brown, Sue A.
Funding for this research was provided by:
U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623, RO1 DK085623)
Article History
Received: 1 March 2025
Accepted: 25 April 2025
First Online: 6 May 2025
Competing interests
: B.P.K. reports research grants handled by the University of Virginia from the National Institutes of Health, Novo Nordisk, Dexcom, and Tandem Diabetes Care. Additionally, B.P.K. has patents with royalties paid to Dexcom and Novo Nordisk, handled by the University of Virginia Licensing and Ventures Group. P.C. is at present an employee of Dexcom, Inc.; the work presented in this article was performed as part of his UVA appointment and is independent of his employment with Dexcom, Inc. J.P. has received research support through his previous institution from Dexcom. J.D.C. is at present an employee of Insulet Corp.; the work presented in this article was performed as part of her UVA appointment and is independent of her employment with Insulet. M.V.T., C.L.K., G.S., C.A. declare no conflicts. M.S. has received support to her institution from Dexcom, Insulet and Tandem Diabetes Care. S.A.B. has received research support through her institution from Dexcom, Insulet, Roche Diagnostics, Tandem Diabetes Care and Tolerion and has participated on a data monitoring board for MannKind.